The Vivalytic platform is a universal, fully automated all in one solution for molecular diagnostics. It is a cartridge-based platform enabling High-Plex and Low-Plex testing developed in partnership with Bosch. Vivalytic consolidates the full molecular workflow into a small benchtop platform, capable of extraction, PCR amplification and detection. Randox multiplex Biochip Technology powers Vivalytic enabling multiple results from one patient sample.
Randox patented Biochip Technology allows simultaneous detection of multiple targets from a single patient sample. The biochip detection system is based on a chemiluminescent signal, this is the emission of light, without heat, as a result of a chemical reaction. Each biochip is prefabricated with spatially discrete testing regions (DTR’s). Each DTR represents an individual test. Each DTR can be occupied with oligonucleotides specific to a pathogen or target of interest. The High-Plex capabilities of Biochip Technology eliminates the need to run multiple time consuming and sample intensive assays.
Key Benefits:
- Fully automated, sample to answer point of care diagnostics
- Unique test menu covering a diverse range of respiratory, genitourinary and hospital acquired infections including SARS-CoV-2 (COVID-19)
- Wireless connectivity, no peripherals required making Vivalytic a unique space-saving & hygienic solution
- Full molecular workflow consolidated into one small benchtop platform
- High-Plex & Low-Plex Capabilities. Powered by Randox Biochip Technology enabling multiple results from one patient sample
- Easy 4 step process from sample entry to results. No laboratory training required